21 November 2017
News and Views
Links and Services
This month's issue of the Journal of Viral Hepatitis compares 48 weeks with 72 weeks of pegylated interferon and ribavirin for treatment naïve chronic hepatitis C genotype 1 late viral responders.
Patients with genotype I chronic hepatitis C virus infection with late virological response to th
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors